Melatonin Guidelines for Circadian Rhythm Sleep Disorders

Introduction to Melatonin Therapy

The American Academy of Sleep Medicine recommends melatonin 3-5 mg taken 1.5-2 hours before desired bedtime for circadian rhythm sleep disorders, but advises against its use in older adults with dementia due to lack of benefit and potential harm 1, 2

For adults with Delayed Sleep-Wake Phase Disorder (DSWPD), start with 5 mg melatonin administered between 19:00-21:00 (7-9 PM) for 28 days, which improved total sleep time by 41-56 minutes and reduced sleep latency by 37-44 minutes in clinical trials 1, 3
The American Academy of Sleep Medicine provides a WEAK FOR recommendation for this use, acknowledging LOW quality evidence 1, 3
For children and adolescents with DSWPD, use weight-based dosing: 0.15 mg/kg (approximately 1.6-4.4 mg) for children without comorbidities, and fixed dosing for psychiatric comorbidities: 3 mg if <40 kg, 5 mg if >40 kg 3, 4
For children with Autism Spectrum Disorder or ADHD, start with 1-3 mg immediate-release melatonin 30-60 minutes before desired bedtime, and reassess response after 1-2 weeks using sleep diaries 4

The American Academy of Sleep Medicine recommends AGAINST melatonin for irregular sleep-wake rhythm disorder in older adults with dementia, due to lack of benefit and potential harm, including detrimental effects on mood and daytime functioning 2, 5
Instead, implement morning bright light therapy at 2,500-5,000 lux for 1-2 hours daily between 9:00-11:00 AM for older adults with dementia 5

Starting with 3 mg is more appropriate than higher doses, as receptor saturation and desensitization occur with doses ≥10 mg 4
The dose-response relationship is not linear, and higher doses (10 mg) cause receptor desensitization and more frequent adverse effects, including morning headache and sleepiness 4

Most clinical trial data supports melatonin use for 4 weeks or less, with a maximum recommended duration for chronic insomnia of 3-4 months 4
The American Academy of Sleep Medicine explicitly states long-term use is not recommended due to insufficient safety data beyond several months 4

Common side effects include daytime sleepiness (1.66%), headache (0.74%), dizziness (0.74%), and nausea, with gastrointestinal upset reported more frequently at higher doses 4
Use with caution in patients taking warfarin due to potential interactions, and exercise caution in patients with epilepsy based on case reports 4

Administration 1.5-2 hours before desired bedtime is optimal for most circadian rhythm disorders, with earlier timing relative to DLMO producing greater phase advances 1, 3, 4

When stopping after prolonged use, taper gradually over several weeks to months to minimize rebound insomnia, and consider tapering frequency rather than daily use 4

Since melatonin is contraindicated in older adults with dementia, implement morning bright light therapy, maximize daytime sunlight exposure, increase physical and social activities during daytime, establish structured bedtime routine, and reduce nighttime light and noise exposure 5
Strictly avoid benzodiazepines and hypnotics due to high risk of falls, cognitive decline, and confusion 5

The American Academy of Sleep Medicine recommends against the use of melatonin for the treatment of chronic insomnia in adults (WEAK AGAINST recommendation) due to low-quality evidence showing minimal benefit and equal risk, based on studies with a 2mg dosage 6

The American Academy of Sleep Medicine provides a WEAK FOR recommendation for the use of melatonin in specific situations, such as circadian rhythm sleep disorders, although the quality of evidence is low 6
The use of melatonin in ICU patients has shown no significant improvement in sleep quality and quantity, leading the Society of Critical Care Medicine to not recommend its use for sleep improvement in critically ill patients 7

The quality of melatonin products is a concern in the US due to lack of FDA regulation, which may affect their efficacy and consistency 7

Melatonin has been shown to be effective in treating delayed sleep-wake phase disorder (DSWPD), with optimal timing being 1.5-2 hours before desired bedtime, although the evidence quality is low 6
The timing of melatonin administration is crucial, as earlier administration relative to the dim light melatonin onset (DLMO) can result in greater phase advancement, while inappropriate timing can reduce efficacy or have adverse effects 8